Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis

PURPOSE: For high-risk prostate cancer (HR-PCa) in men with a life expectancy of at least 10 years, the National Comprehensive Cancer Network recommends radiation therapy (RT) plus androgen deprivation therapy (ADT) with category 1 evidence or radical prostatectomy (RP) as an acceptable initial ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Markovina, Stephanie, Meeks, Marshall W., Badiyan, Shahed, Vetter, Joel, Gay, Hiram A., Paradis, Alethea, Michalski, Jeff, Sandhu, Gurdarshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000029/
https://www.ncbi.nlm.nih.gov/pubmed/29904744
http://dx.doi.org/10.1016/j.adro.2017.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000029/
https://www.ncbi.nlm.nih.gov/pubmed/29904744
http://dx.doi.org/10.1016/j.adro.2017.12.001

Ejemplares similares